Optimization of prostate needle biopsy for focal targeted therapy in prostate cancer

Optimization of prostate needle biopsy for focal targeted therapy in prostate cancer - Optimization of prostate needle biopsy for focal targeted therapy in prostate cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000029223

Enrollment

Registered

2017-09-23

Start date

2017-10-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate cancer

Interventions

Targeted biopsy

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: Male patients suspicious of cancer who have targeted region with PI-RADS score 3 or more by MRI

Exclusion criteria

Exclusion criteria: Patients with a contraindication for the administration of gadolinium contrast media. Patients determined to be ineligible to principal investigator

Design outcomes

Primary

Measure	Time frame
Efficiency of detecting prostate cancer with gleason score 7 or higher from targeted regions	—

Countries

Japan

Contacts

Public ContactTakumi Shiraishi

Kyoto Prefectural University of Medicine Department of Urology

takumi14@koto.kpu-m.ac.jp075-251-5595

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026